Development and Information Services, Finnish Medicines Agency, Kuopio/Tampere, P.O. Box 55, FI-00034, Fimea, Finland.
School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
Drugs Aging. 2024 Aug;41(8):665-674. doi: 10.1007/s40266-024-01131-y. Epub 2024 Jul 31.
The Finnish web-based Meds75+ database supports rational, safe and appropriate prescribing to older adults in primary care. This article describes the content and updating process of Meds75+ and demonstrates its applicability in everyday clinical practice. Meds75+ contains a classification (A-D) and recommendation texts for 450-500 drug substances when used in the treatment of older adults aged 75 years or older. The content of Meds75+ is continually updated. Each assessment of a drug substance begins with a structured collection of available information and research evidence. After that, an interdisciplinary expert panel discusses the classification and recommendation using a consensus method. A rolling 3-year updating cycle guarantees that all drug substances are reviewed regularly. Most drug substances are classified as class A (41%) (suitable, e.g. bisoprolol) or as class C (37%) (suitable with specific precautions, e.g. ibuprofen). One-fifth (20%) of the substances are in class D (avoid use, e.g. diazepam). Most commonly, older adults have purchased substances affecting the alimentary tract and metabolism (17%), the nervous system (16%) and the cardiovascular system (15%). In Finland, the proportion of older adults using class D substances (37%) has not changed between the years 2019 and 2022. Meds75+ has potential to support safer and more effective use of medications for older adults, since it offers up-to-date information on drug substances for healthcare professionals.
芬兰基于网络的 Meds75+ 数据库支持初级保健中老年患者合理、安全和适当的处方。本文介绍了 Meds75+ 的内容和更新过程,并展示了其在日常临床实践中的适用性。Meds75+ 包含了一个分类(A-D)和 450-500 种药物物质的推荐文本,用于治疗 75 岁及以上的老年人。Meds75+ 的内容不断更新。每种药物物质的评估都从收集现有信息和研究证据开始。然后,一个跨学科的专家小组使用共识方法讨论分类和推荐。三年滚动更新周期保证了所有药物物质都能定期审查。大多数药物物质被分类为 A 类(41%)(适用,如比索洛尔)或 C 类(37%)(适用但有特定注意事项,如布洛芬)。五分之一(20%)的物质属于 D 类(避免使用,如地西泮)。最常见的是影响消化道和新陈代谢(17%)、神经系统(16%)和心血管系统(15%)的药物物质。在芬兰,2019 年至 2022 年期间,使用 D 类物质(37%)的老年患者比例没有变化。Meds75+ 为医疗保健专业人员提供了最新的药物信息,有可能支持更安全和更有效的老年患者药物使用。